ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106995 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106995; 2) Community: the network communities that were significantly associated with the response to NSC 106995; 3) Molecule: the relationships between components within communities and NSC 106995; 4) MDR: the compounds that were significantly associated with the NSC 106995.

NSC Compound Enrichment Correlation
NSC 759016 Null 0.0348927754043157 0.016705324
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0348927754043159 0.2623186
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0348927754043159 0.18976276
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0348927754043159 0.043527004
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0348927754043159 0.26265431
NSC 281818 Ethanol, 2,2'-[[3-methyl-4-[[[4-[2-(4-propoxyphenyl]-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.0348927754043159 0.034942511
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0348927754043159 0.46186224
NSC 313681 Oxiperomide(USAN) 0.0348927754043159 0.2767123
NSC 328410 Camptothecin Derivative 0.0348927754043159 0.18529852
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0348927754043159 0.40416371
Total:57  Current:38    [First] [Prev] [Next] [Last]